Skip to main content
. 2016 Apr 26;18(6):590–597. doi: 10.1111/dom.12654

Figure 2.

DOM-12654-FIG-0002-c

(A) Effect of dapagliflozin versus placebo on glycated haemoglobin (HbA1c) and effect of dapagliflozin on urine albumin/creatinine ratio (UACR) stratified by HbA1c response. (B) Effect of dapagliflozin versus placebo on systolic blood pressure (SBP) and effect of dapagliflozin on UACR stratified by SBP response.